After a longstanding global presence, malaria is now largely non-existent or suppressed in most parts of the world. Today, cases and deaths are primarily concentrated in sub-Saharan Africa. According to many experts, this persistence on the African continent reflects factors such as resistance to insecticides and drugs as well as insufficient access to essential commodities such as insecticide-treated nets and effective drugs. Crucially, however, this narrative ignores many central weaknesses in the fight against malaria and instead reinforces a narrow, commodity-driven vision of disease control. This paper therefore describes the core challenges hindering malaria programs in Africa and highlights key opportunities to rethink current strategies for sustainable control and elimination. The epidemiology of malaria in Africa presents far greater challenges than elsewhere and requires context-specific initiatives tailored to national and sub-national targets. To sustain progress, African countries must systematically address key weaknesses in its health systems, improve the quality and use of data for surveillance-responses, improve both technical and leadership competencies for malaria control, and gradually reduce overreliance on commodities while expanding multisectoral initiatives such as improved housing and environmental sanitation. They must also leverage increased funding from both domestic and international sources, and support pivotal research and development efforts locally. Effective vaccines and drugs, or other potentially transformative technologies such as genedrive modified mosquitoes, could further accelerate malaria control by complementing current tools. However, our underlying strategies remain insufficient and must be expanded to include more holistic and context-specific approaches critical to achieve and sustain effective malaria control.
The health crisis emerging from China in January 2020 has spread around the world resulting in a disruption of daily life activity in many countries. In response to this health threat, different measures have been implemented by national governments to minimize the possible health consequences. This article explores the initial impact of the COVID-19 pandemic in Spain, providing an epidemiological overview and reviewing the early measures developed to control its spread. On 1 April, Spain was the country with the second highest incidence in the world; with 104,118 positive cases detected and 9387 deaths recorded. Among these, 20.2% of positive cases were among healthcare professionals. In addition to the unprecedented health crisis, the lockdown interventions employed were considered to be among the strictest measures implemented through European countries. These measures were initially successful in controlling local transmission, but resulted in severe economic and social impacts. A critical review of the actions taken and their impact on the Spanish population could contribute to guide and inform decision-making in future pandemic situations.
The EDCTP-TDR Clinical Research and Development Fellowship (CRDF) scheme has offered one-year clinical research training placements for early- and mid-career researchers from LMIC since 1999.Using ...
The Manhiça Health Research Center (CISM)is a well-established research center with a strong and consolidated research capacity into communicable diseases prevalent in Mozambique, with particular focus on the main causes of morbidity and mortality. Since its creation, CISM has grown within the framework of a bilateral cooperation programme between the Mozambican and Spanish governments and with support from the Hospital Clinic (HC) and the University of Barcelona (UB) to fight diseases and protect the health of vulnerable populations through research, healthcare and training. In 2008 the Manhiça Foundation was created representing one of the most important events in the development of the Centre because it entitled CISM to a Mozambican legal framework, which facilitates its sustainability and long-term autonomy. In 2010, as part of this strategy for integration and country ownership, the Foundation for Community Development and Eduardo Mondlane University joined as partners. And in 2015, the Barcelona Institute for Global Health replaced the HC and the UB. One of the key strategies of this partnership to build CISM’s research environment has been the training of staff through the joint development of capacity building and strengthening activities. After 27 years of successful collaboration, a Training Fellowship Programme has been established to train young African graduates wishing to develop their career as researchers; the program provides hands-on training within research projects implemented at CISM. Many training courses and workshops have been developed to train clinical researchers, technicians, data managers, etc.; and networks with other Sub-Saharan African countries have been established to strengthen research capacities (e.g., TESA). All these efforts succeeded in awarding 114 postgraduate degrees in collaboration with North and South universities all over the world for both African and international students: 63 doctorates and 47 master; more than 140 research and training internships; and more than 10 funded collaborative projects.